Rossari Biotech logo

Rossari Biotech MD, chairman, board of directors and AGM

NSE: ROSSARIBSE: 543213Chemicals & PetrochemicalsSmall Cap

Last close ₹414.70down ₹12.60 (2.95%)BSE ₹414.80

Share price at the NSE close on 23 Oct 2026. Previous close ₹427.30.

52-week range of traded prices to 23 Oct 2026
₹375.00Low, 30 Mar 2026₹663.00High, 28 Oct 2025
Market cap
₹2,297 Cr1,009th largest listed
P/E
15.0
P/B
1.6
Dividend yield
0.12%
ROE
11.5%
ROCE
12.1%
Debt to equity
0.26
Volume, NSE
1,81,48259.5% delivered

Rossari Biotech board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonEdward MenezesRelated to the promoter
  • Managing directorSunil Srinivasan Chari
  • Company Secretary and Compliance OfficerParul Gupta

6 directors4 independent2 executive

  • Edward Menezes · ChairpersonExecutive · joined Aug 2009 · reappointed Oct 2024 · 1 listed board
  • Sunil Srinivasan Chari · Managing directorExecutive · joined Aug 2009 · reappointed Oct 2024 · 1 listed board · 3 committee seats
  • Aseem DhruIndependent · joined Nov 2019 · reappointed Nov 2024 · 82 months as independent · 3 listed boards · 2 as independent · 4 committee seats, 4 as chair
  • Esha Padmanabhan AchanIndependent · joined Oct 2023 · reappointed Oct 2023 · 35 months as independent · 2 listed boards · 2 as independent · 5 committee seats, 2 as chair
  • Gurudas Vishwas ArasIndependent · joined Oct 2024 · reappointed Oct 2024 · 23 months as independent · 3 listed boards · 3 as independent · 5 committee seats, 3 as chair
  • Udeypaul Singh GillIndependent · joined Apr 2026 · reappointed Apr 2026 · 5 months as independent · 3 listed boards · 3 as independent · 2 committee seats, 1 as chair

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

2 directors who left
  • Aparna Sharma, left 28 Apr 2026: Tenure Completion
  • Sharabh Pachory, left 11 Nov 2024: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 18 Jul 20266 of 6 present4 independent · 51 days in between
    • 27 May 20266 of 6 present4 independent · 29 days in between
    • 27 Apr 20266 of 6 present4 independent

  • Audit Committee

    Chair Aseem Dhru

    Esha Padmanabhan Achan, Gurudas Vishwas Aras, Udeypaul Singh Gill

    • 18 Jul 20264 of 4 present4 independent · 81 days in between
    • 27 Apr 20264 of 4 present4 independent

  • Nomination and remuneration committee

    Chair Gurudas Vishwas Aras

    Esha Padmanabhan Achan, Udeypaul Singh Gill

    • 27 May 20263 of 3 present3 independent · 29 days in between
    • 27 Apr 20263 of 3 present3 independent

  • Stakeholders Relationship Committee

    Chair Esha Padmanabhan Achan

    Gurudas Vishwas Aras, Sunil Srinivasan Chari

    • 18 Jul 20263 of 3 present2 independent

  • Risk Management Committee

    Chair Sunil Srinivasan Chari

    Edward Menezes, Esha Padmanabhan Achan, Mikhail Menezes

    • 21 Sep 20263 of 3 present1 independent

  • Corporate Social Responsibility Committee

    Chair Edward Menezes

    Gurudas Vishwas Aras, Esha Padmanabhan Achan

    • 27 Apr 20263 of 3 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • Walker Chandiok & Co LLPPeer-review certificate valid to May 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Rossari Biotech AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Rossari Biotech dividend history

Annual general meeting, 20 Jul 2026

89,110 shareholders on the register on 13 Jul 2026; present: 9 promoters and 39 others; votes counted by Swapneel Patel / M/s. Shah Patel and Associates.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone Financial Statement of the Company for the Financial Year ended 31st March, 2026 and the reports of the Board of Directors and Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.18%

    Turnout: all 83.25% · promoters 100.00% · institutions 89.73% · other public 1.35%

  2. To receive, consider and adopt the Audited Consolidated Financial Statement of the Company for the Financial Year ended 31st March, 2026 and the report of Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.18%

    Turnout: all 83.25% · promoters 100.00% · institutions 89.73% · other public 1.35%

  3. To declare a Dividend of Re. 0.50 (25%) per Equity Share of the face value of Rs. 2/- each for the Financial Year ended 31st March, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.18%

    Turnout: all 83.26% · promoters 100.00% · institutions 89.74% · other public 1.35%

  4. To appoint a director in place of Mr. Edward Menezes (DIN: 00149205), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.30%

    Turnout: all 83.26% · promoters 100.00% · institutions 89.74% · other public 1.35%

  5. To consider and approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.42%

    Turnout: all 15.05% · promoters 0.00% · institutions 89.74% · other public 0.93%

  6. To consider and approve the appointment of Mr. Udeypaul Singh Gill (DIN: 00004340), as a Non-Executive, Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.26%

    Turnout: all 83.26% · promoters 100.00% · institutions 89.74% · other public 1.35%

  7. To consider and approve the re-appointment of Ms. Esha Padmanabhan Achan (DIN: 10350369), as a Non-Executive, Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.30%

    Turnout: all 83.26% · promoters 100.00% · institutions 89.74% · other public 1.35%

  8. To ratify the remuneration payable to M/s. R. Shetty & Associates Cost Auditors of the Company for the Financial Year 2026-27.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.19%

    Turnout: all 83.26% · promoters 100.00% · institutions 89.74% · other public 1.35%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jun 2025, 7 resolutions

93,419 shareholders on the register on 23 Jun 2025; present: 9 promoters and 35 others; votes counted by Swapneel Patel / M/s. Shah Patel and Associates.The company's voting result (opens in a new tab)

  1. 1. To receive, consider and adopt the Audited Standalone Financial Statement of the Company for the Financial Year ended 31st March, 2025 and the reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 87.37% · promoters 100.00% · institutions 89.28% · other public 1.55%

  2. 2 - To receive, consider and adopt the Audited Consolidated Financial Statement of the Company for the Financial Year ended 31st March, 2025 and the report of Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 87.37% · promoters 100.00% · institutions 89.28% · other public 1.55%

  3. 3 - To declare a Dividend of Re. 0.50 (25%) per Equity Share of the face value of Rs. 2/- each for the Financial Year ended 31st March, 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 87.37% · promoters 100.00% · institutions 89.29% · other public 1.55%

  4. 4 - To appoint a director in place of Mr. Sunil Chari (DIN: 00149083), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.86% for0.14% against

    Against: promoters 0.00% · institutions 0.64% · other public 0.17%

    Turnout: all 87.37% · promoters 100.00% · institutions 89.29% · other public 1.55%

  5. 5 - To consider and approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited.
    OrdinaryPromoters have an interest in it
    90.36% for9.64% against

    Against: promoters 0.00% · institutions 9.72% · other public 0.20%

    Turnout: all 19.18% · promoters 0.00% · institutions 89.29% · other public 1.37%

  6. 6 - To consider and approve the appointment of M/s. Shah Patel & Associates, as Secretarial Auditors of the Company.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 87.37% · promoters 100.00% · institutions 89.29% · other public 1.55%

  7. 7 - To ratify the remuneration payable to M/s. R. Shetty & Associates Cost Auditors of the Company for the Financial Year 2025-26.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 87.37% · promoters 100.00% · institutions 89.29% · other public 1.55%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Extraordinary general meeting, 11 Nov 2024, 2 resolutions

Present: 9 promoters and 29 others.The company's voting result (opens in a new tab)

  1. To approve appointment of Mr. Gurudas Aras (DIN: 02187903), as a Non-Executive, Independent Director of the Company, not liable to retire by rotation, to hold office for a term of three (3) consecutive years on the Board of the Company commencing from 19th October, 2024 upto 18th October, 2027 (both days inclusive).MoreLess
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.49%

    Turnout: all 82.56% · promoters 92.01% · institutions 93.35% · other public 0.96%

  2. To approve re-appointment of Mr. Aseem Dhru (DIN: 01761455), as a Non-Executive, Independent Director of the Company, not liable to retire by rotation, to hold office for a second term of three (3) consecutive years on the Board of the Company commencing from 12th November, 2024 upto 11th November, 2027 (both days inclusive).MoreLess
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 0.10% · other public 1.49%

    Turnout: all 82.56% · promoters 92.01% · institutions 93.35% · other public 0.96%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 23 Aug 2024, 9 resolutions

Present: 9 promoters and 42 others.The company's voting result (opens in a new tab)

  1. 1 - To receive, consider and adopt Audited Standalone Financial Statement of the Company for the Financial Year ended 31st March, 2024 and the reports of the Board of Directors and Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.16%

    Turnout: all 87.85% · promoters 100.00% · institutions 93.28% · other public 1.12%

  2. 2 - To receive, consider and adopt Audited Consolidated Financial Statement of the Company for the Financial Year ended 31st March, 2024 and the report of Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.16%

    Turnout: all 87.85% · promoters 100.00% · institutions 93.28% · other public 1.12%

  3. 3 - To declare a Dividend of Rs. 0.50/- (25%) per Equity Share of the Face Value of Rs. 2/- each for the Financial Year ended 31st March, 2024.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 87.85% · promoters 100.00% · institutions 93.29% · other public 1.12%

  4. 4 - To appoint a director in place of Mr. Edward Menezes (DIN: 00149205), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.78% for0.23% against

    Against: promoters 0.00% · institutions 1.02% · other public 0.35%

    Turnout: all 87.85% · promoters 100.00% · institutions 93.29% · other public 1.12%

  5. 5 - To consider and approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.17%

    Turnout: all 19.53% · promoters 0.00% · institutions 93.29% · other public 1.12%

  6. 6 - To consider and approve reappointment of Mr. Edward Menezes (DIN:00149205) as a Whole Time Director designated as Executive Chairman of the Company for a period of 5 (five) years commencing from 01st October, 2024 to 30th September, 2029 (both days inclusive), liable to retire by rotation.MoreLess
    SpecialPromoters have an interest in it
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.20% · other public 0.21%

    Turnout: all 50.96% · promoters 46.00% · institutions 93.29% · other public 1.12%

  7. 7 - To consider and approve re-appointment of Mr. Sunil Chari (DIN: 00149083) as the Managing Director of the Company for the further period of 5 (five) years commencing from 01st October, 2024 to 30th September, 2029 (both days inclusive), liable to retire by rotation.MoreLess
    SpecialPromoters have an interest in it
    99.94% for0.06% against

    Against: promoters 0.00% · institutions 0.16% · other public 0.20%

    Turnout: all 50.96% · promoters 46.00% · institutions 93.29% · other public 1.12%

  8. 8 - To consider and approve appointment of Ms. Yashika Chari for holding of office or place of profit /employment in Rossari Global DMCC, a Wholly Owned Subsidiary of the Company.
    OrdinaryPromoters have an interest in it
    94.38% for5.62% against

    Against: promoters 0.00% · institutions 14.74% · other public 0.38%

    Turnout: all 50.96% · promoters 46.00% · institutions 93.29% · other public 1.12%

  9. 9 - To ratify and approve the remuneration of the Cost Auditors of the Company for the Financial Year 2024-25.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.31%

    Turnout: all 87.85% · promoters 100.00% · institutions 93.29% · other public 1.12%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 6 Dec 2023, 4 resolutions

The company's voting result (opens in a new tab)

  1. To approve appointment of Ms. Esha Padmanabhan Achan (DIN: 10350369) as a Non-Executive, Independent Director of the Company for a term of Three (3) consecutive years commencing from 21st October, 2023 upto 20th October, 2026 (both days inclusive).MoreLess
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.54%

    Turnout: all 86.79% · promoters 100.00% · institutions 78.61% · other public 1.08%

  2. To approve overall borrowing limits under Section 180(1)(c) of the Companies Act, 2013
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.35%

    Turnout: all 86.79% · promoters 100.00% · institutions 78.61% · other public 1.08%

  3. To grant approval under Section 180(1)(a) of the Companies Act, 2013 inter alia for creation of mortgage or charge on the assets, properties or undertaking(s) of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.42%

    Turnout: all 86.79% · promoters 100.00% · institutions 78.61% · other public 1.08%

  4. To approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.31%

    Turnout: all 18.45% · promoters 0.00% · institutions 78.61% · other public 1.08%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 31 May 2023, 10 resolutions

Present: 9 promoters and 41 others.The company's voting result (opens in a new tab)

  1. To consider and Adopt of the audited standalone financial statement of the Company for the Financial Year ended 31st March, 2023 and the reports of the Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.42% · promoters 100.00% · institutions 93.48% · other public 1.46%

  2. To consider and Adopt of the audited consolidated financial statement of the Company for the Financial Year ended 31st March, 2023 and the reports of the Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.42% · promoters 100.00% · institutions 93.48% · other public 1.46%

  3. To declare a Dividend of Re. 0.50 (25%) per Equity Share of the Face Value of Rs. 2 each for the Financial Year ended 31st March 2023
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.42% · promoters 100.00% · institutions 93.48% · other public 1.46%

  4. To appoint a Director in place of Mr. Sunil Chari (DIN: 00149083), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 90.42% · promoters 100.00% · institutions 93.48% · other public 1.46%

  5. To appoint M/s. Walker Chandiok & Co LLP, Chartered Accountants as Statutory Auditors of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 90.42% · promoters 100.00% · institutions 93.48% · other public 1.46%

  6. To appoint Ms. Aparna Sharma (DIN: 07132341), as a Non-Executive, Independent Director of the Company
    Special
    97.21% for2.79% against

    Against: promoters 0.00% · institutions 11.52% · other public 0.17%

    Turnout: all 90.42% · promoters 100.00% · institutions 93.48% · other public 1.46%

  7. To consider and approve Payment of Commission to the Non-executive Directors of the Company
    Special
    93.65% for6.35% against

    Against: promoters 0.00% · institutions 26.25% · other public 0.17%

    Turnout: all 90.42% · promoters 100.00% · institutions 93.48% · other public 1.46%

  8. To consider and approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.05%

    Turnout: all 21.99% · promoters 0.00% · institutions 93.48% · other public 1.46%

  9. To consider and approve Amendment in Rossari Biotech Limited Employee Stock Option Plan 2019
    Special
    97.78% for2.22% against

    Against: promoters 0.00% · institutions 9.19% · other public 0.03%

    Turnout: all 90.42% · promoters 100.00% · institutions 93.48% · other public 1.46%

  10. To ratify and approve the remuneration of the Cost Auditors for the Financial Year 2023-24
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 90.42% · promoters 100.00% · institutions 93.48% · other public 1.46%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 15 Jul 2022, 7 resolutions

Present: 9 promoters and 52 others.The company's voting result (opens in a new tab)

  1. To receive consider and adopt the Audited Financial Statements (including the consolidated Financial Statements) of the Company for the Financial Year ended 31st March 2022 together with the Reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.96%

    Turnout: all 88.79% · promoters 100.00% · institutions 89.50% · other public 9.61%

  2. To declare a Dividend of Re. 0.50 (25%) per Equity Share of the Face Value of Rs. 2 each for the Financial Year ended 31st March 2022
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.97%

    Turnout: all 88.79% · promoters 100.00% · institutions 89.50% · other public 9.61%

  3. To appoint a Director in place of Mr. Edward Menezes (DIN: 00149205), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.60% for0.40% against

    Against: promoters 0.00% · institutions 1.80% · other public 0.97%

    Turnout: all 88.79% · promoters 100.00% · institutions 89.50% · other public 9.61%

  4. To Continue directorship of Mr. Goutam Bhattacharya (DIN: 00917357), Director in terms of Regulation 17(1A) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015MoreLess
    Special
    99.96% for0.04% against

    Against: promoters 0.00% · institutions 0.14% · other public 0.98%

    Turnout: all 88.79% · promoters 100.00% · institutions 89.50% · other public 9.61%

  5. To Alter/Delete the Main and Other Object Clause of the Memorandum of Association of the Company
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.01%

    Turnout: all 88.79% · promoters 100.00% · institutions 89.50% · other public 9.61%

  6. To consider and approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited
    OrdinaryPromoters have an interest in it
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.01%

    Turnout: all 20.23% · promoters 0.00% · institutions 89.50% · other public 9.61%

  7. To ratify and approve the remuneration of the Cost Auditors for the Financial Year 2022-23
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.01%

    Turnout: all 88.79% · promoters 100.00% · institutions 89.50% · other public 9.61%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 17 Sep 2021, 4 resolutions

Present: 9 promoters and 56 others.The company's voting result (opens in a new tab)

  1. 1 - To receive, consider and adopt:na.tAudited Financial Statements of the Company for the Financial Year ended March 31, 2021 together with the Reports of Board ofnDirectors and Auditors thereon.nb.tAudited Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2021 together with the Report of Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.05%

    Turnout: all 88.00% · promoters 100.00% · institutions 87.38% · other public 6.34%

  2. To declare Final Dividend @ 25% (i.e. Rs 0.50/-) per Equity Share for 2020-21.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.05%

    Turnout: all 88.00% · promoters 100.00% · institutions 87.38% · other public 6.34%

  3. To appoint a Director in place of Mr. Sunil Chari (DIN: 00149083), Director, who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.08% · other public 0.06%

    Turnout: all 88.00% · promoters 100.00% · institutions 87.38% · other public 6.34%

  4. To ratify and approve the remuneration of the Cost Auditors for the Financial Year 2021-22
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.23%

    Turnout: all 88.00% · promoters 100.00% · institutions 87.38% · other public 6.34%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 30 Jun 2025, 8 fund houses

  • 1. To receive, consider and adopt the Audited Standalone Financial Statement of the Company for the Financial Year ended 31st March, 2025 and the reports of the Board of Directors and Auditors thereon.MoreLess
    8 for0 against
  • 2 - To receive, consider and adopt the Audited Consolidated Financial Statement of the Company for the Financial Year ended 31st March, 2025 and the report of Auditors thereon
    8 for0 against
  • 3 - To declare a Dividend of Re. 0.50 (25%) per Equity Share of the face value of Rs. 2/- each for the Financial Year ended 31st March, 2025.
    8 for0 against
  • 4 - To appoint a director in place of Mr. Sunil Chari (DIN: 00149083), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    8 for0 against
  • 5 - To consider and approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited.
    Against Angel One Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Angel One Mutual FundGovernance & Transparency Concern: In absence of adequate disclosures, it is unclear how proposed transactions relating to purchase & sale of fixed assets fall within the ordinary course of business.
    • Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance & Transparency Concern: In absence of adequate disclosures, it is unclear how proposed transactions relating to purchase & sale of fixed assets fall within the ordinary course of business.
    5 for3 against
  • 6 - To consider and approve the appointment of M/s. Shah Patel & Associates, as Secretarial Auditors of the Company.
    8 for0 against
  • 7 - To ratify the remuneration payable to M/s. R. Shetty & Associates Cost Auditors of the Company for the Financial Year 2025-26.
    8 for0 against

Mutual fund votes, meeting of 11 Nov 2024, 5 fund houses

  • To approve appointment of Mr. Gurudas Aras (DIN: 02187903), as a Non-Executive, Independent Director of the Company, not liable to retire by rotation, to hold office for a term of three (3) consecutive years on the Board of the Company commencing from 19th October, 2024 upto 18th October, 2027 (both days inclusive).MoreLess
    5 for0 against
  • To approve re-appointment of Mr. Aseem Dhru (DIN: 01761455), as a Non-Executive, Independent Director of the Company, not liable to retire by rotation, to hold office for a second term of three (3) consecutive years on the Board of the Company commencing from 12th November, 2024 upto 11th November, 2027 (both days inclusive).MoreLess
    5 for0 against
5 earlier meetings

Mutual fund votes, meeting of 23 Aug 2024, 4 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • 1 - To receive, consider and adopt Audited Standalone Financial Statement of the Company for the Financial Year ended 31st March, 2024 and the reports of the Board of Directors and Auditors thereon.
    4 for0 against
  • 2 - To receive, consider and adopt Audited Consolidated Financial Statement of the Company for the Financial Year ended 31st March, 2024 and the report of Auditors thereon.
    Against Groww Mutual Fund
    • Groww Mutual FundUnqualified financial statements. Compliant with Indian Accounting Standards. Non-Compliant with Sec 136(1) of the Companies Act: Non-disclosure of the audited financial statements of a subsidiary on the website of the Company.
    3 for1 against
  • 3 - To declare a Dividend of Rs. 0.50/- (25%) per Equity Share of the Face Value of Rs. 2/- each for the Financial Year ended 31st March, 2024.
    4 for0 against
  • 4 - To appoint a director in place of Mr. Edward Menezes (DIN: 00149205), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    Against Bandhan Mutual Fund, Groww Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual FundRe-appointment compliant with law. Governance concern: Combined position of Chairman and Executive Director.
    2 for2 against
  • 5 - To consider and approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited.
    Against Bandhan Mutual Fund, Groww Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual FundCompliant with law. Governance & Transparency Concern: In absence of adequate disclosures, it is unclear how proposed transactions relating to purchase & sale of fixed assets fall within the ordinary course of business.
    2 for2 against
  • 6 - To consider and approve reappointment of Mr. Edward Menezes (DIN:00149205) as a Whole Time Director designated as Executive Chairman of the Company for a period of 5 (five) years commencing from 01st October, 2024 to 30th September, 2029 (both days inclusive), liable to retire by rotation.MoreLess
    Against Bandhan Mutual Fund, Groww Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual FundRe-appointment compliant with law. Governance concern: Combined position of Chairman and Executive Director.
    2 for2 against
  • 7 - To consider and approve re-appointment of Mr. Sunil Chari (DIN: 00149083) as the Managing Director of the Company for the further period of 5 (five) years commencing from 01st October, 2024 to 30th September, 2029 (both days inclusive), liable to retire by rotation.MoreLess
    4 for0 against
  • 8 - To consider and approve appointment of Ms. Yashika Chari for holding of office or place of profit /employment in Rossari Global DMCC, a Wholly Owned Subsidiary of the Company.
    4 for0 against
  • 9 - To ratify and approve the remuneration of the Cost Auditors of the Company for the Financial Year 2024-25.
    1 for0 against
1 proposal not matched to one resolution
  • Ratification of remuneration of Rs. 1,20,000/- plus taxes and reimbursement of out of pocket expenses at actuals payable to M/s. R. Shetty and Associates, Cost Accountants (Firm Registration No.: 101455), to conduct cost audit relating to cost records of the Company under the Companies (Cost Records and Audit) Rules, 2015 (including any statutory modification(s), amendment(s), clarification(s), substitution(s) or reenactment(s) thereof for the time being in force) for the Financial Year ending 31st March, 2025.MoreLess
    3 for0 against

Mutual fund votes, meeting of 6 Dec 2023, 7 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To approve appointment of Ms. Esha Padmanabhan Achan (DIN: 10350369) as a Non-Executive, Independent Director of the Company for a term of Three (3) consecutive years commencing from 21st October, 2023 upto 20th October, 2026 (both days inclusive).MoreLess
    7 for0 against
  • To approve overall borrowing limits under Section 180(1)(c) of the Companies Act, 2013
    1 for0 against
  • To grant approval under Section 180(1)(a) of the Companies Act, 2013 inter alia for creation of mortgage or charge on the assets, properties or undertaking(s) of the Company.
    7 for0 against
  • To approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited.
    7 for0 against
1 proposal not matched to one resolution
  • To borrowing, from time to time, by way of loans, credit facilities, debt instruments or in any other forms, any such sum or sums of money (either Indian or foreign currency) from banks, financial institutions, bodies corporate, companies, firms or any one or more persons on such terms and conditions and with or without security as the Board may think fit, for the purpose of business of the Company, any sum or sums of monies which together with the monies already borrowed by the Company (apart from temporary loans obtained or to be obtained from the Company’s bankers in the ordinary course of business), which may exceed the aggregate of the paid up capital of the Company, its free reserves and securities premium, provided that the total amount so borrowed by the Board shall not at any time exceed the aggregate of the paid up capital, free reserves and securities premium of the Company or Rs.5,000 million.MoreLess
    6 for0 against

Mutual fund votes, meeting of 31 May 2023, 6 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To consider and Adopt of the audited standalone financial statement of the Company for the Financial Year ended 31st March, 2023 and the reports of the Board of Directors and Auditors thereon
    6 for0 against
  • To consider and Adopt of the audited consolidated financial statement of the Company for the Financial Year ended 31st March, 2023 and the reports of the Board of Directors and Auditors thereon
    6 for0 against
  • To declare a Dividend of Re. 0.50 (25%) per Equity Share of the Face Value of Rs. 2 each for the Financial Year ended 31st March 2023
    6 for0 against
  • To appoint a Director in place of Mr. Sunil Chari (DIN: 00149083), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    6 for0 against
  • To appoint M/s. Walker Chandiok & Co LLP, Chartered Accountants as Statutory Auditors of the Company
    6 for0 against
  • To appoint Ms. Aparna Sharma (DIN: 07132341), as a Non-Executive, Independent Director of the Company
    6 for0 against
  • To consider and approve Payment of Commission to the Non-executive Directors of the Company
    6 for0 against
  • To consider and approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited
    6 for0 against
  • To consider and approve Amendment in Rossari Biotech Limited Employee Stock Option Plan 2019
    6 for0 against
  • To ratify and approve the remuneration of the Cost Auditors for the Financial Year 2023-24
    2 for0 against
1 proposal not matched to one resolution
  • Ratification of remuneration of Rs.100,000/- plus taxes and reimbursement of out of pocket expenses at actual payable to M/s. R. Shetty & Associates, Cost Accountants (Firm Registration No.:101455), to conduct cost audit relating to cost records of the Company under the Companies (Cost Records and Audit) Rules, 2015 (including any statutory modification(s) or re-enactment(s) thereof for the time being in force) for the Financial Year ending 31st March, 2024.MoreLess
    4 for0 against

Mutual fund votes, meeting of 15 Jul 2022, 6 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive consider and adopt the Audited Financial Statements (including the consolidated Financial Statements) of the Company for the Financial Year ended 31st March 2022 together with the Reports of the Board of Directors and Auditors thereon.MoreLess
    6 for0 against
  • To declare a Dividend of Re. 0.50 (25%) per Equity Share of the Face Value of Rs. 2 each for the Financial Year ended 31st March 2022
    6 for0 against
  • To appoint a Director in place of Mr. Edward Menezes (DIN: 00149205), who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    6 for0 against
  • To Continue directorship of Mr. Goutam Bhattacharya (DIN: 00917357), Director in terms of Regulation 17(1A) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015MoreLess
    6 for0 against
  • To Alter/Delete the Main and Other Object Clause of the Memorandum of Association of the Company
    6 for0 against
  • To consider and approve Material Related Party Transaction(s) with Unitop Chemicals Private Limited
    6 for0 against
  • To ratify and approve the remuneration of the Cost Auditors for the Financial Year 2022-23
    2 for0 against
3 proposals not matched to one resolution
  • Ratification of remuneration payable to M/s. R. Shetty & Associates, Cost Accountants (Firm Registration No.:101455), to conduct cost audit relating to cost records of the Company under the Companies (Cost Records and Audit) Rules, 2015 (including any statutory modification(s) or re-enactment(s) thereof for the time being in force) for the Financial Year ending 31st March, 2023 on a remuneration of Rs. 1,00,000/- (Rupees One Lakhs only) per annum plus Tax as applicable.MoreLess
    2 for0 against
  • Ratification of remuneration payable to M/s. R. Shetty & Associates, Cost Accountants (Firm Registration No.:101455), to conduct cost audit relating to cost records of the Company under the Companies (Cost Records and Audit) Rules, 2015 (including any statutory modification(s) or re-enactment(s) thereof for the time being in force) for the Financial Year ending 31st March, 2023 on a remuneration of ? 1,00,000/- (Rupees One Lakhs only) per annum plus Tax as applicable.MoreLess
    1 for0 against
  • To appoint M/s. R. Shetty & Associates, Cost Accountants (Firm Registration No.:101455), to conduct cost audit relating to cost records of the Company under the Companies (Cost Records and Audit) Rules, 2015 (including any statutory modification(s) or re-enactment(s) thereof for the time being in force) for the Financial Year ending 31st March, 2023 on a remunerationMoreLess
    1 for0 against

Mutual fund votes, meeting of 17 Sep 2021, 8 fund houses

  • 1 - To receive, consider and adopt:na.tAudited Financial Statements of the Company for the Financial Year ended March 31, 2021 together with the Reports of Board ofnDirectors and Auditors thereon.nb.tAudited Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2021 together with the Report of Auditors thereon.MoreLess
    8 for0 against
  • To declare Final Dividend @ 25% (i.e. Rs 0.50/-) per Equity Share for 2020-21.
    8 for0 against
  • To appoint a Director in place of Mr. Sunil Chari (DIN: 00149083), Director, who is liable to retire by rotation and being eligible, offers himself for re-appointment.
    8 for0 against
  • To ratify and approve the remuneration of the Cost Auditors for the Financial Year 2021-22
    8 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.